Genetic Signatures Limited

Genetic Signatures Limited is a molecular diagnostics company specializing in the development and commercialization of proprietary real-time PCR-based detection systems for infectious disease screening. The company's core platform, 3base™, utilizes streamlined sample processing methods linked to highly multiplexed real-time PCR assays to simultaneously detect multiple pathogen targets faster than conventional methods. Primary product line includes the EasyScreen™ brand of detection kits, which employ DNA methylation pattern identification and sequence simplification technology. The company has achieved FDA 510(k) clearance for the EasyScreen™ Gastrointestinal Parasite Detection Kit, now distributed through leading US clinical laboratories. Additional offerings include Analyte Specific Reagents (ASRs) for laboratory-developed test applications. Genetic Signatures serves clinical laboratories, diagnostic facilities, and healthcare systems requiring rapid, multiplexed infectious disease identification. The company maintains regulatory compliance with FDA standards and positions itself as a specialist in molecular diagnostics innovation, with particular expertise in gastrointestinal parasite and pathogen detection. Operations span both US and international markets, with documented presence in the US healthcare diagnostics sector.